Literature DB >> 35286707

The Immunogenetic Aspects of Photodynamic Therapy.

Chaw-Ning Lee1, Tak-Wah Wong2,3,4.   

Abstract

Photodynamic therapy (PDT) has become the first-line treatment of actinic keratosis, superficial basal cell carcinoma, and squamous cell carcinoma in situ (Bowen's disease) in dermatology. The off-label use of PDT has also escalated in recent years owing to its applications in the treatment of various non-neoplastic skin diseases such as acne vulgaris, vascular lesions, rejuvenation, and chronic wounds. Daylight PDT that uses natural sunlight to activate a photosensitizer with advantages such as low cost and reduced pain is widely used in Europe. This chapter reviews the applications and immunogenetic aspects of PDT. However, the studies of immunity and genetic changes in human tissue after PDT are limited.
© 2022. Springer Nature Switzerland AG.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35286707     DOI： 10.1007/978-3-030-92616-8_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  90 in total

Review 1.  The history of photodetection and photodynamic therapy.

Authors:  R Ackroyd; C Kelty; N Brown; M Reed
Journal:  Photochem Photobiol       Date:  2001-11       Impact factor: 3.421

Review 2.  Laser and non-laser light sources for photodynamic therapy.

Authors:  L Brancaleon; H Moseley
Journal:  Lasers Med Sci       Date:  2002       Impact factor: 3.161

3.  Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers.

Authors:  L Bagazgoitia; J Cuevas Santos; A Juarranz; P Jaén
Journal:  Br J Dermatol       Date:  2011-05-26       Impact factor: 9.302

4.  Fluorouracil Enhances Photodynamic Therapy of Squamous Cell Carcinoma via a p53-Independent Mechanism that Increases Protoporphyrin IX levels and Tumor Cell Death.

Authors:  Sanjay Anand; Kishore R Rollakanti; Nikoleta Brankov; Douglas E Brash; Tayyaba Hasan; Edward V Maytin
Journal:  Mol Cancer Ther       Date:  2017-03-23       Impact factor: 6.261

5.  Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.

Authors:  A Asilian; M Davami
Journal:  Clin Exp Dermatol       Date:  2006-06-15       Impact factor: 3.470

6.  Comparative study of the bactericidal effects of indocyanine green- and methyl aminolevulinate-based photodynamic therapy on Propionibacterium acnes as a new treatment for acne.

Authors:  Seung-Hwan Choi; Jeong-Wan Seo; Ki-Ho Kim
Journal:  J Dermatol       Date:  2018-05-03       Impact factor: 4.005

7.  Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy.

Authors:  N Basset-Seguin; R Bissonnette; C Girard; M Haedersdal; J T Lear; C Paul; S Piaserico
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-04-13       Impact factor: 6.166

8.  Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer.

Authors:  William Wei Lim Chin; Paul Wan Sia Heng; Patricia Soo Ping Thong; Ramaswamy Bhuvaneswari; Werner Hirt; Sebastian Kuenzel; Khee Chee Soo; Malini Olivo
Journal:  Eur J Pharm Biopharm       Date:  2008-03-10       Impact factor: 5.571

9.  Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.

Authors:  Joana Cabete; Margarida Rafael; Mariana Cravo; Cecília Moura; Fernanda Sachse; Manuela Pecegueiro
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

10.  Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods.

Authors:  Caerwyn Ash; Michael Dubec; Kelvin Donne; Tim Bashford
Journal:  Lasers Med Sci       Date:  2017-09-12       Impact factor: 3.161
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.